Janus Kinase Inhibitor Tofacitinib Shows Potent Efficacy in a Mouse Model of Autoimmune Lymphoproliferative Syndrome (ALPS)

PURPOSE: Autoimmune lymphoproliferative syndrome (ALPS) is a non-malignant genetic disorder of lymphocyte homeostasis with defective Fas-mediated apoptosis. Current therapies for ALPS primarily target autoimmune manifestations with non-specific immune suppressants with variable success thus highligh...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Immunol
Main Authors: Yokoyama, Seiji, Perera, Pin-Yu, Terawaki, Seigo, Watanabe, Nobumasa, Kaminuma, Osamu, Waldmann, Thomas A., Hiroi, Takachika, Perera, Liyanage P.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7780245/
https://ncbi.nlm.nih.gov/pubmed/26453583
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10875-015-0203-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados